Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MEETINGS - Technology Acquisition: The Impact of Clinical Trials (US) October 1998:

This article was originally published in Clinica

Executive Summary

The Association for the Advancement of Medical Instrumentation will hold a meeting entitled Technology Acquisition: The Impact of Clinical Trials on October 9-10 in Baltimore. Representatives from the Health Care Financing Administration, the FDA and industry will discuss topics such as requirements for clinical trial design and outcomes; interpretation of safety and effectiveness in premarket approval process; and new guidelines for premarket approval of Class III devices by means of a product development protocol. The government's views on technology assessment and clinical trials will also be presented. Delegates will be able to participate in a mock clinical trial developed by the FDA to train its reviewers. For more information contact AAMI in the US. Fax: +1 703 525 1424.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts